Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Clinical trial NCT00307541 · COMPLETED

Trial details

NCT number: NCT00307541
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Streptococcal Streptococcus Pneumoniae Vaccines

Start date: 2005-10-27
Primary completion: 2006-04-07
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.